The Clinical Significance of Lobular Neoplasia on Breast Core Biopsy
- 1 May 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 31 (5), 717-723
- https://doi.org/10.1097/01.pas.0000213408.41182.1f
Abstract
A core biopsy diagnosis of atypical ductal epithelial hyperplasia is upstaged on follow-up excisional biopsy (FUEB) to in situ or invasive carcinoma in about 20% of cases, thus prompting a FUEB. In contrast, upstaging information for a core biopsy diagnosis of pure lobular neoplasia (LN), without mass lesions or other risk-associated lesions is less clear. In this retrospective study, we report the largest consecutive series of patients who had a breast core biopsy diagnosis of LN and a FUEB. Core needle breast biopsies with a diagnosis of LN were retrieved from our files for the period 1999 to 2005, yielding 110 patients. One hundred and one patients had a follow-up surgical excision. Cases of LN with coexisting high-risk lesions (n=9, 10%) were excluded from the study. Patients with associated mass lesions all had benign findings (n=15, 16%) and had no impact on the study results. The remaining 77 core biopsies had no masses or risk lesions and were mammographically Breast Imaging Reporting and Data System 4 (BIRADS) for microcalcifications. Overall, 8/77 (10%) of patients with a radiographic BIRADS 4 image with calcifications and a core biopsy diagnosis of LN on core biopsy were upstaged on FUEB to ductal carcinoma in situ or invasive carcinoma. The numbers upstaged from core biopsies were as follows: atypical lobular hyperplasia (ALH) 4/52 (8%), mixed ALH/lobular carcinoma in situ (LCIS) 1/9 (10%), and pure LCIS 3/16 (19%). A core biopsy of LCIS with neoplastic epithelial calcifications was nearly 3 times more likely to be upstaged on FUEB compared with ALH. We conclude that a finding of LN on breast core biopsy in a patient with a BIRADS 4 image and calcifications is associated with a risk of 8% to 19% of upstaging to a treatable disease on FUEB.Keywords
This publication has 35 references indexed in Scilit:
- Follow-up Surgical Excision Is Indicated When Breast Core Needle Biopsies Show Atypical Lobular Hyperplasia or Lobular Carcinoma In SituThe American Journal of Surgical Pathology, 2005
- Lobular neoplasia on core‐needle biopsy—Clinical significanceCancer, 2004
- Invasive Mammary Carcinoma After Immediate and Short-Term Follow-up for Lobular Neoplasia on Core BiopsyThe American Journal of Surgical Pathology, 2003
- The Significance of Atypical Lobular Hyperplasia at Percutaneous Breast BiopsyThe Breast Journal, 2003
- The Management of Lobular Neoplasia Identified on Percutaneous Core Breast BiopsyThe Breast Journal, 2003
- Atypical Lobular Hyperplasia or Lobular Carcinoma in Situ at Core-Needle Breast BiopsyRadiology, 2001
- Vacuum-Assisted Stereotactic Breast BiopsyArchives of Surgery, 2000
- Atypical hyperplasia in the era of stereotactic core needle biopsyJournal of Surgical Oncology, 1998
- Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American PathologistsCA: A Cancer Journal for Clinicians, 1997
- The James Ewing lecture current concepts in the detection and treatment of the earliest of the early breast cancersCancer, 1970